Browsing Tag
HER2-negative breast cancer
2 posts
Genentech’s giredestrant shows breakthrough survival benefit in early breast cancer: What lidERA revealed
Genentech’s giredestrant delivers historic survival benefit in early-stage breast cancer. Explore how the lidERA trial may redefine endocrine therapy.
Gilead’s $21bn cancer gamble faces major blow as Trodelvy fails in key breast cancer trial
Gilead’s Trodelvy failed to meet the main goal in a Phase 3 breast cancer trial, raising new questions about its oncology growth strategy.